LEAH WALLER: Open Payments
NPI 1740673250 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 38 payments from 16 companies in 2025. Trend: 2023 $5,835 · 2024 $1,483 · 2025 $976
Food & beverage: $976
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $187 |
| REVANCE THERAPEUTICS, INC. | 1 | $125 |
| PFIZER INC. | 4 | $85 |
| UCB, Inc. | 3 | $74 |
| Incyte Corporation | 3 | $73 |
| Regeneron Healthcare Solutions, Inc. | 2 | $68 |
| ABBVIE INC. | 4 | $65 |
| LEO Pharma Inc. | 2 | $56 |
| Organon LLC | 2 | $56 |
| Lilly USA, LLC | 2 | $37 |
Products named: DAXXIFY, Rhapsido, DUPIXENT, CIBINQO, Bimzelx, OPZELURA, SKYRIZI, SOFDRA.
Industry payments across VA — which companies pay providers there.
